Announcing: Cochlear (ASX:COH) Stock Increased An Energizing 234% In The Last Five Years

In This Article:

Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card!

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put in. But on a lighter note, a good company can see its share price rise well over 100%. Long term Cochlear Limited (ASX:COH) shareholders would be well aware of this, since the stock is up 234% in five years. It's also good to see the share price up 19% over the last quarter.

View our latest analysis for Cochlear

While the efficient markets hypothesis continues to be taught by some, it has been proven that markets are over-reactive dynamic systems, and investors are not always rational. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).

During five years of share price growth, Cochlear achieved compound earnings per share (EPS) growth of 28% per year. This EPS growth is remarkably close to the 27% average annual increase in the share price. Therefore one could conclude that sentiment towards the shares hasn't morphed very much. In fact, the share price seems to largely reflect the EPS growth.

The graphic below depicts how EPS has changed over time (unveil the exact values by clicking on the image).

ASX:COH Past and Future Earnings, June 28th 2019
ASX:COH Past and Future Earnings, June 28th 2019

We consider it positive that insiders have made significant purchases in the last year. Even so, future earnings will be far more important to whether current shareholders make money. It might be well worthwhile taking a look at our free report on Cochlear's earnings, revenue and cash flow.

What About Dividends?

As well as measuring the share price return, investors should also consider the total shareholder return (TSR). The TSR is a return calculation that accounts for the value of cash dividends (assuming that any dividend received was reinvested) and the calculated value of any discounted capital raisings and spin-offs. So for companies that pay a generous dividend, the TSR is often a lot higher than the share price return. As it happens, Cochlear's TSR for the last 5 years was 270%, which exceeds the share price return mentioned earlier. The dividends paid by the company have thusly boosted the total shareholder return.

A Different Perspective

Cochlear provided a TSR of 7.4% over the last twelve months. But that was short of the market average. If we look back over five years, the returns are even better, coming in at 30% per year for five years. Maybe the share price is just taking a breather while the business executes on its growth strategy. It is all well and good that insiders have been buying shares, but we suggest you check here to see what price insiders were buying at.